Trade CYCN anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Cyclerion Therapeutics, Inc. (CYCN) is trading at US$3.90, down 2.21% today as of Aug 28, 13:02 EDT. The company has a market capitalisation of US$18.21M. Over the past 52 weeks, CYCN has traded between US$1.03 and US$8.48. On Syfe you can trade CYCN with $0 commission and add it to your watchlist.
| Previous close | US$3.99 |
|---|---|
| Market cap | US$18.21M |
| 52-week range | US$1.03 – US$8.48 |
| Volume | 97.08K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Cyclerion Therapeutics, Inc.
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
Year: 2019
Top Premarket Decliners
Apr 6, 11:33 AM · MT Newswires
Top Midday Gainers
Apr 1, 5:51 PM · MT Newswires
Cyclerion Therapeutics, Inc. (CYCN) stock is trading at US$3.90, -2.21% from the previous close of US$3.99.
The market cap for Cyclerion Therapeutics, Inc. (CYCN) stock is approximately US$18.21M.
The 52-week high for Cyclerion Therapeutics, Inc. (CYCN) stock is US$8.48.
The 52-week low for Cyclerion Therapeutics, Inc. (CYCN) stock is US$1.03.
Cyclerion Therapeutics, Inc. (CYCN) does not currently pay a dividend.
Stay on top of CYCN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
